Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 11;14(1):16026.
doi: 10.1038/s41598-024-66629-2.

The role of graft cross-linking during keratoplasty in patients with corneal melting

Raphael Kilian  1 , Gerald Schmidinger  2 , Jan Lammer  3
Affiliations

The role of graft cross-linking during keratoplasty in patients with corneal melting

Raphael Kilian et al. Sci Rep. .

Abstract

The purpose of this study was to investigate the role of corneal crosslinking (CXL) of grafts during keratoplasty (KP) in patients with refractory corneal melting (CM). This is a retrospective case series reporting the clinical outcomes of patients who received a crosslinked corneal graft during penetrating or deep anterior lamellar KP for refractory infectious or sterile CMs. Outcome measures were the recurrence of CM, the time required for epithelial healing following KP, incidence of complications, and necessity for re-transplantation. Twenty eyes of 18 patients with a follow-up of 29.2 ± 15.8 months were included in this study. All but two eyes had undergone previous KPs during the course of their disease (mean 1.9 ± 1.6). After CXL-enhanced KP, three eyes (15%) experienced recurrence of CM, three eyes developed an infectious keratitis and six eyes (30%) required a re-transplantation (three of them within 12 months). The mean time to epithelium closure after CXL-enhanced KP was 63 ± 90 days. The number of postoperative re-transplantations was significantly lower than the number of KPs performed before the CXL-enhanced transplantation (before CXL 1.9 ± 1.6 vs after CXL: 0.3 ± 0.57, p = 0.002). To conclude, CXL of the graft at the time of keratoplasty decreased the need for re-transplantations. However, further studies are needed in order to establish its role in the management of severe CM necessitating therapeutic corneal transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Krachmer JH, Mannis MJ, Holland EJ. Cornea: Fundamentals, Diagnosis and Management. 5. Elsevier Inc.; 2021.
    1. Reinprayoon U, Srihatrai P, Satitpitakul V, Puangsricharern V, Wungcharoen T, Kasetsuwan N. Survival outcome and prognostic factors of corneal transplantation: A 15 year retrospective cohort study at King Chulalongkorn Memorial Hospital. Clin. Ophthalmol. 2021;15:4189–4199. doi: 10.2147/OPTH.S336986. - DOI - PMC - PubMed
    1. Sabhapandit S, Murthy SI, Sharma N, Sangwan VS. Surgical management of peripheral ulcerative keratitis: Update on surgical techniques and their outcome. Clin. Ophthalmol. 2022;16:3547–3557. doi: 10.2147/OPTH.S385782. - DOI - PMC - PubMed
    1. Manns RPC, Achiron A, Knyazer B, et al. Use of corneal cross-linking beyond keratoconus: A systemic literature review. Graefes Arch. Clin. Exp. Ophthalmol. 2023 doi: 10.1007/s00417-023-05994-6. - DOI - PubMed
    1. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr. Eye Res. 2004;29(1):35–40. doi: 10.1080/02713680490513182. - DOI - PubMed
-